Botulinum toxin type A is a potential therapeutic drug for chronic orofacial pain

Botulinum toxin type A is a potential therapeutic drug for chronic orofacial pain

Authors: Yu-Mi Kim 1, Jo-Young Son 1, Dong-Kuk Ahn
Publication: Journal of Oral Biosciences
Year: 2024
View Article

The Facial Pain Research Foundation, Inc
2653 SW 87th Drive Suite A
Gainesville FL 32608-9313

Mailing address for Donations and all other correspondences:
4591 W. Higgins Road, Suite 703
Hoffman Estates, IL 60192

info@facingfacialpain.org

Nonprofit 501(c)3 Tax exempt organization. Gifts are tax deductible to the amount allowed by law. EIN 82-1317992

Get Updates On Our Research!

By submitting this form, you are consenting to receive marketing emails from: The Facial Pain Research Foundation. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
Go to Top